Viatris, Inc. recalls Telmisartan and Amlodipine
- Recalling company
- Viatris, Inc.
- Product
- Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg, 30-count Bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA, Made in India, NDC 0378-1075-93.
- Reason
- Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications
- Classification
- Class III – not likely to cause adverse health consequences
- Recall date
- Oct 1, 2026
- Reported
- Oct 28, 2026
- Distribution
- Nationwide in the USA.
- Status
- Ongoing
- Quantity
- 21,620 30-count bottles
- Lot / codes
- Lot # 3228113, 3228114, 3228115, Exp Date: Oct 31, 2026; Lot # 3228120, 3228121, Exp Date: Nov 30, 2026.
- Company location
- Morgantown, WV
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0049-2027
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0049-2027 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.